87 related articles for article (PubMed ID: 16797278)
1. Analysis of L-myc gene polymorphism in patients with renal failure outcome to renal transplant.
Yigit B; Bozkurt N; Yaylim I; Titiz I; Isbir T
Transplant Proc; 2006 Jun; 38(5):1267-9. PubMed ID: 16797278
[TBL] [Abstract][Full Text] [Related]
2. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
3. L-myc gene polymorphism and risk of thyroid cancer.
Yaylim-Eraltan I; Bozkurt N; Ergen A; Zeybek U; Ozturk O; Arikan S; Erbil Y; Uslu I; Camlica H; Isbir T
Exp Oncol; 2008 Jun; 30(2):117-20. PubMed ID: 18566574
[TBL] [Abstract][Full Text] [Related]
4. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
5. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey.
Bektas-Kayhan K; Unür M; Yaylim-Eraltan I; Ergen A; Hafiz G; Karadeniz A; Isbir T
Anticancer Res; 2009 Jul; 29(7):2519-24. PubMed ID: 19596922
[TBL] [Abstract][Full Text] [Related]
6. Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
Zhang WX; Chen B; Zhang W; Chen N; Yu ZC; Cai WM
Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients.
Al-Muhanna F; Al-Mueilo S; Al-Ali A; Larbi E; Rubaish A; Abdulmohsen MF; Al-Zahrani A; Al-Ateeq S
Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):937-41. PubMed ID: 18974580
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of the methylenetetrahydrofolate reductase C677T gene with chronic allograft nephropathy in renal transplant recipients.
Azarpira N; Raisjalali G; Darai M
Exp Clin Transplant; 2008 Mar; 6(1):54-8. PubMed ID: 18405246
[TBL] [Abstract][Full Text] [Related]
9. Study of the association of -667 aquaporin-2 (AQP-2) A/G promoter polymorphism with the incidence and clinical course of chronic kidney disease in Korea.
Kang SW; Kim YW; Kim YH; Sohn HS; Joo H; Kim E
Ren Fail; 2007; 29(6):693-8. PubMed ID: 17763164
[TBL] [Abstract][Full Text] [Related]
10. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease.
Bellini MH; Figueira MN; Piccoli MF; Marumo JT; Cendoroglo MS; Neto MC; Dalboni MA; Batista MC; Goes MA; Schor N
Nephrology (Carlton); 2007 Jun; 12(3):289-93. PubMed ID: 17498125
[TBL] [Abstract][Full Text] [Related]
11. Effects of cholesteryl ester transfer protein TAQ1B polymorphism in renal transplant patients.
Zeybek U; Isbir T; Ergen HA; Yilmaz H; Hekim N; Akoglu E
Transplant Proc; 2006 Jun; 38(5):1382-4. PubMed ID: 16797310
[TBL] [Abstract][Full Text] [Related]
12. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
13. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
14. Restriction fragment length polymorphisms of the human N-myc gene in normal healthy individuals and oral cancer patients in India.
Saranath D; Panchal RG; Deo MG; Sanghvi V; Mehta AR
Indian J Biochem Biophys; 1994 Jun; 31(3):177-83. PubMed ID: 7959843
[TBL] [Abstract][Full Text] [Related]
15. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
16. [Association of alpha-adducin and angiotensin converting enzyme gene polymorphisms with salt-sensitive hypertension and early renal injury].
Lu LH; Chen H; Yu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):132-5. PubMed ID: 18393230
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
18. Effect of apolipoprotein E polymorphism on renal transplantation.
Cofán F; Cofan M; Rosich E; Campos B; Casals E; Zambon D; Ros E; Oppenheimer F; Campistol JM
Transplant Proc; 2007 Sep; 39(7):2217-8. PubMed ID: 17889142
[TBL] [Abstract][Full Text] [Related]
19. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients.
Eren PA; Turan K; Berber I; Canbakan M; Kara M; Tellioglu G; Bugan U; Sevinç C; Turkmen F; Titiz MI
Clin Nephrol; 2009 Aug; 72(2):114-21. PubMed ID: 19640368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
